Nabumetone
Product Images NDC 10544-003

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 10544-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 500mg 60ct (10544 003 60 68462 358 05 Rev1)

Nabumetone Tablets USP 500mg packaging label showing 60 tablets per bottle. The label includes NDC 10544-003-60, manufacturer and packager Blenheim Pharmacal Inc. It states "Rx Only" with storage instructions at 20°-25°C (68°-77°F) and to keep out of reach of children. Barcodes and lot number placeholders are visible on the label.*

FDA Label Image

Structural Formula Of Nabumetone (5276f530 14bc 492d 974b 913fd06bf52e 01)

Chemical structure of Nabumetone, showing the molecular formula C15H16O2 and molecular weight 228.3. The structure depicts aromatic rings, a methoxy group, and a ketone side chain.*

FDA Label Image

6mna (5276f530 14bc 492d 974b 913fd06bf52e 02)

Chemical structure of 6-methoxy-2-naphthylacetic acid (6MNA), a metabolite of Nabumetone as indicated by the label text in the image.*

FDA Label Image

Table 1 (5276f530 14bc 492d 974b 913fd06bf52e 03)

A data table comparing pharmacokinetic parameters including Tmax, t1/2, CLss/F, and Vdss/F among young adults and elderly groups at 1,000 mg and 2,000 mg doses of Nabumetone. Mean values with standard deviations and sample sizes are presented.*

FDA Label Image

6mna Plasma Concentrations (5276f530 14bc 492d 974b 913fd06bf52e 04)

A line graph showing Nabumetone active metabolite (6MNA) plasma concentrations over time at steady state following once-daily dosing of 1000 mg and 2000 mg. Concentrations (mcg/mL) are plotted on the vertical axis against time (hours) on the horizontal axis up to 70 hours, including standard deviation ranges for both dosage groups.*

FDA Label Image

Metabolites (5276f530 14bc 492d 974b 913fd06bf52e 05)

A data table listing the metabolite composition percentages of nabumetone and its related compounds, including 6-methoxy-2-naphthylacetic acid (6MNA) unchanged and conjugated forms, 6-hydroxy-2-naphthylacetic acid (6HNA) unchanged and conjugated forms, 4-(6-hydroxy-2-naphthyl)-butan-2-ol conjugated, O-desmethyl-nabumetone conjugated, and unidentified minor metabolites, with a total percent dose of 73%.*

FDA Label Image

Table 2 (5276f530 14bc 492d 974b 913fd06bf52e 06)

A data table showing Nabumetone dose levels (500 mg to 2,000 mg) with the number of patients for osteoarthritis (OA) and rheumatoid arthritis (RA), alongside mean and mode duration of treatment in years for each group.*

FDA Label Image

Side Effects Table (5276f530 14bc 492d 974b 913fd06bf52e 07)

A drug facts panel listing serious and other side effects of Nabumetone. Serious side effects include heart attack, stroke, high blood pressure, heart failure from fluid retention, kidney problems, bleeding and ulcers in the stomach and intestine, low red blood cells, life-threatening skin and allergic reactions, liver problems, and asthma attacks. Other side effects include stomach pain, constipation, diarrhea, gas, heartburn, nausea, vomiting, and dizziness.*

FDA Label Image

Get Emergency Help If You Experience These Symptoms (5276f530 14bc 492d 974b 913fd06bf52e 08)

A safety warning panel listing severe symptoms requiring medical attention, including shortness of breath or trouble breathing, chest pain, weakness in one part or side of the body, slurred speech, and swelling of the face or throat. The text is presented in two bordered columns for easy reading.*

FDA Label Image

Stop Nsaid If You Experience These Symptoms (5276f530 14bc 492d 974b 913fd06bf52e 09)

A text panel listing possible adverse symptoms or warning signs including nausea, fatigue, itching, yellowing of skin or eyes, stomach pain, flu-like symptoms, vomiting blood, blood in bowel movement or tar-like stool, unusual weight gain, skin rash or blisters with fever, and swelling of extremities.*

FDA Label Image

Nsaid Medications That Need A Prescription (5276f530 14bc 492d 974b 913fd06bf52e 10)

A table listing generic names of various NSAIDs alongside their corresponding tradenames. Nabumetone is listed with the tradename Relafen. Other drugs and their tradenames include Celecoxib (Celebrex), Diclofenac (Cataflam, Voltaren, Arthrotec), and Ibuprofen (Motrin, Tab-Profen, Vicoprofen). The table provides a clear pairing of generic drugs with marketed brand names.*

FDA Label Image

Glenmark Logo (5276f530 14bc 492d 974b 913fd06bf52e 11)

FDA Label Image

Label 750mg 60ct (Label Nabumetone Tabs 750mg Bpi(10544 271 60) Glenmark(68462 359 05) Rev3)

Nabumetone Tablets, USP 750mg label from Blenheim Pharmacal, Inc. The label indicates 60 tablets in the container and is marked Rx Only. It includes storage instructions to keep at controlled room temperature (20°-25°C) and out of reach of children. The label displays the NDC 10544-271-60 and manufacturer number 68462-359-05.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.